13D Filing: Alafi Capital Co LLC and Intra-Cellular Therapies Inc. (ITCI)

Page 2 of 12

Page 2 of 12 – SEC Filing


SCHEDULE 13D
CUSIP No. 46116X 101 Page
2
of 13 Pages
  1 

Name of
reporting person

Alafi Capital Company, LLC

  2

Check the appropriate box if a member
of a group

(a)  ☐        (b)  ☒ (joint filers)

  3

SEC use only

  4

Source of funds

    OO

  5

Check if disclosure of legal
proceedings is required pursuant to Item 2(d) or 2(e)    ☐

  6

Citizenship or place of
organization

    California

Number of

shares

beneficially

owned by

each

reporting

person

with

  7 

Sole voting power

    3,953,270 shares

  8

Shared voting power

    0 shares

  9

Sole dispositive power

    3,953,270 shares

10

Shared dispositive power

    0 shares

11

Aggregate amount beneficially owned by each reporting person

    3,953,270 shares

12

Check if the aggregate amount in Row
(11) excludes certain shares    ☐

13

Percent of class represented by amount
in Row (11)

    7.2%1

14

Type of reporting person

    OO

1 The percentage ownership was calculated based on 54,553,353 shares of common stock of Intra-Cellular Therapies, Inc. (referred to herein as Intra-Cellular or the Issuer) outstanding as ofOctober 5, 2017.

Follow Intra-Cellular Therapies Inc. (NASDAQ:ITCI)

Page 2 of 12